12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

  • Acorda Therapeutics ACOR stock rose 6.7% to $1.92 during Wednesday's after-market session. The company's market cap stands at $21.5 million.
  • Leap Therapeutics LPTX stock moved upwards by 5.26% to $3.0. The market value of their outstanding shares is at $264.9 million.
  • Aytu BioPharma AYTU stock increased by 4.83% to $1.3. The market value of their outstanding shares is at $36.5 million.
  • electroCore ECOR stock increased by 4.18% to $0.72. The company's market cap stands at $50.8 million.
  • Conformis CFMS stock rose 3.32% to $0.64. The company's market cap stands at $119.1 million.
  • Celsion CLSN stock rose 3.14% to $0.45. The company's market cap stands at $38.6 million.

Losers

  • Rockwell Medical RMTI shares decreased by 8.6% to $0.47 during Wednesday's after-market session. The company's market cap stands at $43.7 million.
  • Valneva VALN stock declined by 5.1% to $45.1. The company's market cap stands at $2.3 billion.
  • Brickell Biotech BBI shares declined by 4.74% to $0.29. Today's trading volume for this security ended up closing at 320.1K shares, which is 5.2 percent of its average volume over the last 100 days. The company's market cap stands at $33.5 million.
  • Absci ABSI stock fell 4.42% to $6.5. The market value of their outstanding shares is at $601.8 million.
  • Reviva Pharmaceuticals RVPH shares decreased by 4.26% to $1.8. The company's market cap stands at $25.1 million.
  • Evofem Biosciences EVFM stock declined by 3.59% to $0.47. The company's market cap stands at $76.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABSI Logo
ABSIAbsci Corp
$2.843.65%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
23.07
Growth
Not Available
Quality
Not Available
Value
7.07
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...